The total, recommended funding for the fiscal year 2007 budget for the National Drug Control Strategy is $12.7 billion, an increase of $109.1 million over the FY 2006 budget. Highlights for the FY 2007 Budget are presented within three key priority areas: Priority I--stopping use before it starts: education and community action; Priority II--intervening and healing America’s drug users; and Priority III--disrupting the market. Under Priority I, the Department of Education, Student Drug Testing would receive $15.0 million and research-based grant assistance to local educational agencies $52 million and the Office of National Drug Control Policy’s media campaign would receive $120.0 million. Under Priority II, the National Institute on Drug Abuse (NIDA) would receive $41.6 million for the development of new ways to treat methamphetamine addiction, the Substance Abuse and Mental Health Services Administration (SAMHSA) would receive $98.2 million for access to recovery and the Office of Justice programs, Drug Court Program would receive $69.2 million. Under Priority III, the Department of State, Andean Counterdrug Initiative would receive $721.5 million, Customs and Border Protection, Secure Border Initiative would receive an additional $152.4 million, Community Oriented Policing Services (COPS) would receive $40.1 million in cleaning up methamphetamine laboratories, and the Drug Enforcement Administration would receive an increase of $12.8 million in the prevention of drug flow through Foreign-deployed Advisory Support Teams (FAST) and Operation Panama Express. Agency budget summaries are presented for the Departments of Defense, Education, Health and Human Services, Homeland Security, Justice, State, Transportation, Treasury, as well as Veterans Affairs, Office of National Drug Control Policy, and the U.S. Small Business Administration. In addition to the drug control funding, two modifications to the drug control budget methodologies from prior years are incorporated under the Department of Veterans Affairs and the Office of National Drug Control Policy.